| Cell line name |
YN |
|---|
| Accession |
CVCL_Y579 |
|---|
| Resource Identification Initiative |
To cite this cell line use: YN (RRID:CVCL_Y579) |
|---|
| Comments |
Population: Japanese.
Doubling time: 36.2 hours (Note=At 8th passage), 21.6 hours (Note=At 47th passage) (PubMed=3541491). |
|---|
| Disease |
Embryonal rhabdomyosarcoma (NCIt: C8971)
Embryonal rhabdomyosarcoma (ORDO: Orphanet_99757) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
15Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=3541491; DOI=10.1111/j.1440-1827.1986.tb02821.x
Teiichi Motoyama, Hidenobu Watanabe, Takahiko Yamamoto;
Embryonal rhabdomyosarcoma in nude mice and in vitro.
Acta Pathol. Jpn. 36:1495-1505(1986) CLPUB00569
Paul S. Dickman, Maria G. Tsokos, Timothy J. Triche;
Biology of rhabdomyosarcoma: cell culture, xenografts, and animal models.
(In book chapter) Rhabdomyosarcoma and related tumors in children and adolescents; Maurer, Harold M. & Ruymann, Frederick Beeman & Pochedly, Carl Eugene (eds.); pp.49-88; CRC Press; Boca Raton; USA (1991) PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458
Ashley R.P. Hinson, Rosanne Jones, Lisa E.S. Crose, Brian C. Belyea, Frederic G. Barr, Corinne Mary Linardic;
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.
Front. Oncol. 3:183.1-183.12(2013) PubMed=23665679; DOI=10.1038/onc.2013.129
Elizabeth I. Sokolowski, Claire B. Turina, Ken Kikuchi, David M. Langenau, Charles Keller;
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Oncogene 33:1877-1889(2014) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54995453
|
|---|
| Entry history |
|---|
| Entry creation | 10-Apr-2015 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 8 |
|---|
